National Institutes of Health Director to Step Down by Year’s End

The longtime Director of the National Institutes of Health, Dr. Francis Collins, announced on Tuesday that he will be stepping down from his position by the end of 2021, CNN reports.

In a statement released on Tuesday, Collins called it “an incredible privilege to lead this great agency for more than a decade.”

Read More

Fauci’s Agency Dumped Millions into Chinese Entities to Study Infectious Diseases Since 2012, Federal Data Shows

The National Institutes of Health has doled out nearly $46 million in taxpayer funds to 100 Chinese institutions in the form of subgrants since the 2012 fiscal year to conduct research into infectious diseases, drug addiction, mental health and other scientific fields, according to a Daily Caller News Foundation analysis of federal spending data.

Read More

ASU Professor Says Parents Should Lose Veto Power Over Children’s Transgender Medical Decisions

An Arizona State University (ASU) professor asserts that parents shouldn’t have a say when it comes to their children’s transgender medical decisions. These sentiments appeared in an article by ASU assistant philosophy professor and bioethicist Maura Priest, published early last month by the National Institutes of Health (NIH).

Priest argues that only the child can decide what’s best for them when it comes to medical treatments for transitioning genders. 

Read More

US Grant to Wuhan Lab to Enhance Bat-Based Coronaviruses Was Never Scrutinized by HHS Review Board, NIH Says

An oversight board created to scrutinize research that would enhance highly dangerous pathogens did not review a National Institutes of Health grant that funded a lab in Wuhan, China, to genetically modify bat-based coronaviruses.

Experts say the NIH grant describes scientists conducting gain-of-function research, a risky area of study that, in this case, made SARS-like viruses even more contagious. Federal funding for gain-of-function research was temporarily suspended in 2014 due to widespread scientific concerns it risked leaking supercharged viruses into the human population.

Read More

GOP Lawmakers Demand Investigation into National Institutes of Health’s Relationship with Wuhan Lab

Dozens of Republican members of Congress wrote a letter to National Institutes of Health Acting Inspector General Christi Grimm on Tuesday demanding a “prompt and thorough investigation” into the NIH’s relationship with a Chinese lab that studied coronaviruses.

The 28 lawmakers demanded Grimm investigate the total amount of funding the Wuhan Institute of Virology (WIV) has received from the NIH, as well as whether any NIH officials communicated with the lab or its U.S. sponsor at the onset of the COVID-19 pandemic to quell debate surrounding the theory that the virus could have accidentally escaped from the lab.

Read More

Former Ohio State University Researcher Lies About Grant Applications, Uses Funds to Develop Medicine for China

Song Guo Zheng, a former researcher at Ohio State University and Penn State University, pleaded guilty to using millions in federal grants to increase medical expertise for China.

Zheng — a professor who led an autoimmune research team for both universities — received $4.1 million in funding from the National Institutes of Health for research projects. Instead of using the funds to benefit the United States, he developed China’s expertise in immunology, according to the Department of Justice.

Read More

Moderna’s COVID-19 Vaccine 94.5 Percent Effective in Phase Three Study

Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective.

The company said it intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration in the coming weeks and expects the EUA to be based on the final analysis of 151 cases and a median follow-up of more than two months.

Read More

Minnesota Lifts Statewide Ban on Hydroxychloroquine

Governor Walz lifted the restrictions on access to hydroxychloroquine, a drug that has been in use for decades to treat a wide variety of illnesses – including SARS-type infections – that some say may be an effective therapeutic for COVID-19. The removal of limitations on the drug were outlined in Walz’s latest executive order issued last week.

Walz did not give an explanation for the reversal of his order on the drug.

Read More